Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST)
Surgery is the standard treatment for primary, gastrointestinal stromal tumor (GIST); however, surgical resection often is not curative, particularly in large GIST. Five years after complete removal of their tumor, approximately half of treated patients relapse. Imatinib, an oral tyrosine kinase inh...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
21 April 2010
|
| In: |
Annals of surgical oncology
Year: 2010, Volume: 17, Issue: 10, Pages: 2585-2600 |
| ISSN: | 1534-4681 |
| DOI: | 10.1245/s10434-010-1053-9 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-010-1053-9
|
| Author Notes: | Peter Hohenberger, MD, PhD and Burton Eisenberg, MD |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1839164573 | ||
| 003 | DE-627 | ||
| 005 | 20230710151009.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230314s2010 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1245/s10434-010-1053-9 |2 doi | |
| 035 | |a (DE-627)1839164573 | ||
| 035 | |a (DE-599)KXP1839164573 | ||
| 035 | |a (OCoLC)1389807453 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Hohenberger, Peter |d 1953- |e VerfasserIn |0 (DE-588)1025311469 |0 (DE-627)72202875X |0 (DE-576)370195574 |4 aut | |
| 245 | 1 | 0 | |a Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST) |c Peter Hohenberger, MD, PhD and Burton Eisenberg, MD |
| 264 | 1 | |c 21 April 2010 | |
| 300 | |b Diagramme | ||
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.03.2023 | ||
| 520 | |a Surgery is the standard treatment for primary, gastrointestinal stromal tumor (GIST); however, surgical resection often is not curative, particularly in large GIST. Five years after complete removal of their tumor, approximately half of treated patients relapse. Imatinib, an oral tyrosine kinase inhibitor (TKI), is first-line treatment in patients with metastatic or unresectable GIST. It has resulted in durable objective responses or stable disease in 84% of patients and is well tolerated. The efficacy of imatinib in advanced GIST has created interest in a variety of potential multimodal approaches to management that combine surgery with systemic therapy. | ||
| 650 | 4 | |a Adjuvant Imatinib | |
| 650 | 4 | |a Advanced GIST | |
| 650 | 4 | |a Gastrointestinal Stromal Tumors (GIST) | |
| 650 | 4 | |a Primary GIST | |
| 650 | 4 | |a Unresectable GIST | |
| 700 | 1 | |a Eisenberg, Burton |e VerfasserIn |0 (DE-588)128338230X |0 (DE-627)1839164913 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of surgical oncology |d Berlin [u.a.] : Springer, 1994 |g 17(2010), 10 vom: Apr., Seite 2585-2600 |h Online-Ressource |w (DE-627)343969947 |w (DE-600)2074021-9 |w (DE-576)099879212 |x 1534-4681 |7 nnas |a Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST) |
| 773 | 1 | 8 | |g volume:17 |g year:2010 |g number:10 |g month:04 |g pages:2585-2600 |g extent:16 |a Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST) |
| 856 | 4 | 0 | |u https://doi.org/10.1245/s10434-010-1053-9 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20230314 | ||
| 993 | |a Article | ||
| 994 | |a 2010 | ||
| 998 | |g 1025311469 |a Hohenberger, Peter |m 1025311469:Hohenberger, Peter |d 60000 |d 61800 |e 60000PH1025311469 |e 61800PH1025311469 |k 0/60000/ |k 1/60000/61800/ |p 1 |x j |y j | ||
| 999 | |a KXP-PPN1839164573 |e 4290076084 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"pubHistory":["1.1994 -"],"title":[{"title":"Annals of surgical oncology","title_sort":"Annals of surgical oncology","subtitle":"the official journal of the Society of Surgical Oncology"}],"id":{"zdb":["2074021-9"],"issn":["1534-4681"],"eki":["343969947"]},"origin":[{"dateIssuedDisp":"1994-","dateIssuedKey":"1994","publisherPlace":"Berlin [u.a.] ; Philadelphia, Pa.","publisher":"Springer ; Lippincott Williams & Wilkins"}],"part":{"year":"2010","extent":"16","text":"17(2010), 10 vom: Apr., Seite 2585-2600","issue":"10","volume":"17","pages":"2585-2600"},"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST)Annals of surgical oncology","note":["Gesehen am 26.09.25"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"343969947","corporate":[{"display":"Society of Surgical Oncology","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"]}],"origin":[{"dateIssuedDisp":"21 April 2010","dateIssuedKey":"2010"}],"id":{"doi":["10.1245/s10434-010-1053-9"],"eki":["1839164573"]},"person":[{"given":"Peter","family":"Hohenberger","role":"aut","roleDisplay":"VerfasserIn","display":"Hohenberger, Peter"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Eisenberg, Burton","given":"Burton","family":"Eisenberg"}],"note":["Gesehen am 14.03.2023"],"recId":"1839164573","language":["eng"],"physDesc":[{"extent":"16 S.","noteIll":"Diagramme"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Peter Hohenberger, MD, PhD and Burton Eisenberg, MD"]},"title":[{"title":"Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST)","title_sort":"Role of surgery combined with kinase inhibition in the management of gastrointestinal stromal tumor (GIST)"}]} | ||
| SRT | |a HOHENBERGEROLEOFSURG2120 | ||